A smart drug delivery system from charge-conversion polymer-drug conjugate for enhancing tumor therapy and tunable drug release

Macromol Biosci. 2014 Apr;14(4):485-90. doi: 10.1002/mabi.201300337.

Abstract

A smart drug delivery system is prepared by citraconylated polyaspartic acid (PASP) derivate-drug conjugate. The conjugate contains two pH-sensitive groups: citraconic amide and hydrazone linker. Citraconic amide group can enhance tumor therapy efficiency by the extracellular pH-sensitive charge-conversion property. Hydrazone linker between polymer and drug can cleave efficiently in the intracellular pH environment. The resulting conjugate shows dual-pH sensitive properties: extracellular pH-triggered enhanced tumor targeting and intracellular pH-triggered drug release. The results of physicochemical properties, intracellular location, and cytotoxicity of conjugate micelles demonstrate that this novel smart drug delivery system can enhance intracellular delivery of drug at a low pH and then release drug rapidly.

Keywords: amphiphiles; biomaterials; charge transfer; conjugated polymers; drug delivery systems.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antinematodal Agents / chemistry*
  • Antinematodal Agents / therapeutic use
  • Biocompatible Materials / chemistry
  • Biocompatible Materials / therapeutic use
  • Drug Delivery Systems*
  • Drug Liberation
  • Humans
  • Hydrogen-Ion Concentration
  • Neoplasms / drug therapy*
  • Peptides / chemistry
  • Peptides / therapeutic use
  • Polymers / chemistry*
  • Polymers / therapeutic use

Substances

  • Antinematodal Agents
  • Biocompatible Materials
  • Peptides
  • Polymers
  • polyaspartate